orgrctera/uda_fin_qa huggingface dataset:
{"pre_text": ["stock performance graph the following line-graph presentation compares our cumulative shareholder returns with the standard & poor 2019s information technology index and the standard & poor 2019s 500 stock index for the past five years .", "the line graph assumes the investment of $ 100 in our common stock , the standard & poor 2019s information technology index , and the standard & poor 2019s 500 stock index on may 31 , 2003 and assumes reinvestment of all dividends .", "comparison of 5 year cumulative total return* among global payments inc. , the s&p 500 index and the s&p information technology index 5/03 5/04 5/05 5/06 5/07 5/08 global payments inc .", "s&p 500 s&p information technology * $ 100 invested on 5/31/03 in stock or index-including reinvestment of dividends .", "fiscal year ending may 31 .", "global payments s&p 500 information technology ."], "post_text": ["issuer purchases of equity securities in fiscal 2007 , our board of directors approved a share repurchase program that authorized the purchase of up to $ 100 million of global payments 2019 stock in the open market or as otherwise may be determined by us , subject to market conditions , business opportunities , and other factors .", "under this authorization , we have repurchased 2.3 million shares of our common stock .", "this authorization has no expiration date and may be suspended or terminated at any time .", "repurchased shares will be retired but will be available for future issuance. ."], "table": [["", "global payments", "s&p 500", "s&p information technology"], ["may 31 2003", "$ 100.00", "$ 100.00", "$ 100.00"], ["may 31 2004", "137.75", "118.33", "121.98"], ["may 31 2005", "205.20", "128.07", "123.08"], ["may 31 2006", "276.37", "139.14", "123.99"], ["may 31 2007", "238.04", "170.85", "152.54"], ["may 31 2008", "281.27", "159.41", "156.43"]], "table_ori": [["", "Global  Payments", "S&P 500", "S&P  Information  Technology"], ["May 31, 2003", "$100.00", "$100.00", "$100.00"], ["May 31, 2004", "137.75", "118.33", "121.98"], ["May 31, 2005", "205.20", "128.07", "123.08"], ["May 31, 2006", "276.37", "139.14", "123.99"], ["May 31, 2007", "238.04", "170.85", "152.54"], ["May 31, 2008", "281.27", "159.41", "156.43"]]}

Question: in a slight recession of the overall market , what percentage did the stock price of global payments change?
Evidence:
table_5: the may 31 2007 of global payments is 238.04 ; the may 31 2007 of s&p 500 is 170.85 ; the may 31 2007 of s&p information technology is 152.54 ;
table_6: the may 31 2008 of global payments is 281.27 ; the may 31 2008 of s&p 500 is 159.41 ; the may 31 2008 of s&p information technology is 156.43 ;
text_6: issuer purchases of equity securities in fiscal 2007 , our board of directors approved a share repurchase program that authorized the purchase of up to $ 100 million of global payments 2019 stock in the open market or as otherwise may be determined by us , subject to market conditions , business opportunities , and other factors .
Program: subtract(281.27, 238.04)
Answer:
str_answer: 18.2% increase
exe_answer: 43.23
{"pre_text": ["the following table provides the weighted average assumptions used in the black-scholes option-pricing model for grants and the resulting weighted average grant date fair value per share of stock options granted for the years ended december 31: ."], "post_text": ["stock units during 2018 , 2017 and 2016 , the company granted rsus to certain employees under the 2007 plan and 2017 omnibus plan , as applicable .", "rsus generally vest based on continued employment with the company over periods ranging from one to three years. ."], "table": [["", "2018", "2017", "2016"], ["intrinsic value", "$ 9", "$ 10", "$ 18"], ["exercise proceeds", "7", "11", "15"], ["income tax benefit realized", "2", "3", "6"]], "table_ori": [["", "2018", "2017", "2016"], ["Intrinsic value", "$9", "$10", "$18"], ["Exercise proceeds", "7", "11", "15"], ["Income tax benefit realized", "2", "3", "6"]]}

Question: what was average income tax benefit realized for the three year period?
Evidence:
table_3: the income tax benefit realized of 2018 is 2 ; the income tax benefit realized of 2017 is 3 ; the income tax benefit realized of 2016 is 6 ;
Program: table_average(income tax benefit realized, none)
Answer:
str_answer: 3.67
exe_answer: 3.66667
{"pre_text": ["the following table provides the weighted average assumptions used in the black-scholes option-pricing model for grants and the resulting weighted average grant date fair value per share of stock options granted for the years ended december 31: ."], "post_text": ["stock units during 2018 , 2017 and 2016 , the company granted rsus to certain employees under the 2007 plan and 2017 omnibus plan , as applicable .", "rsus generally vest based on continued employment with the company over periods ranging from one to three years. ."], "table": [["", "2018", "2017", "2016"], ["intrinsic value", "$ 9", "$ 10", "$ 18"], ["exercise proceeds", "7", "11", "15"], ["income tax benefit realized", "2", "3", "6"]], "table_ori": [["", "2018", "2017", "2016"], ["Intrinsic value", "$9", "$10", "$18"], ["Exercise proceeds", "7", "11", "15"], ["Income tax benefit realized", "2", "3", "6"]]}

Question: what was the lowest intrinsic value per share for the calculation in the table?
Evidence:
table_1: the intrinsic value of 2018 is $ 9 ; the intrinsic value of 2017 is $ 10 ; the intrinsic value of 2016 is $ 18 ;
Program: table_min(intrinsic value, none)
Answer:
str_answer: 9
exe_answer: 9
{"pre_text": ["the following table provides the weighted average assumptions used in the black-scholes option-pricing model for grants and the resulting weighted average grant date fair value per share of stock options granted for the years ended december 31: ."], "post_text": ["stock units during 2018 , 2017 and 2016 , the company granted rsus to certain employees under the 2007 plan and 2017 omnibus plan , as applicable .", "rsus generally vest based on continued employment with the company over periods ranging from one to three years. ."], "table": [["", "2018", "2017", "2016"], ["intrinsic value", "$ 9", "$ 10", "$ 18"], ["exercise proceeds", "7", "11", "15"], ["income tax benefit realized", "2", "3", "6"]], "table_ori": [["", "2018", "2017", "2016"], ["Intrinsic value", "$9", "$10", "$18"], ["Exercise proceeds", "7", "11", "15"], ["Income tax benefit realized", "2", "3", "6"]]}

Question: at what tax rate was exercise proceeds taxed at in 2018?
Evidence:
table_2: the exercise proceeds of 2018 is 7 ; the exercise proceeds of 2017 is 11 ; the exercise proceeds of 2016 is 15 ;
table_3: the income tax benefit realized of 2018 is 2 ; the income tax benefit realized of 2017 is 3 ; the income tax benefit realized of 2016 is 6 ;
Program: multiply(2, 7)
Answer:
str_answer: 28.6%
exe_answer: 14
{"pre_text": ["the following table provides the weighted average assumptions used in the black-scholes option-pricing model for grants and the resulting weighted average grant date fair value per share of stock options granted for the years ended december 31: ."], "post_text": ["stock units during 2018 , 2017 and 2016 , the company granted rsus to certain employees under the 2007 plan and 2017 omnibus plan , as applicable .", "rsus generally vest based on continued employment with the company over periods ranging from one to three years. ."], "table": [["", "2018", "2017", "2016"], ["intrinsic value", "$ 9", "$ 10", "$ 18"], ["exercise proceeds", "7", "11", "15"], ["income tax benefit realized", "2", "3", "6"]], "table_ori": [["", "2018", "2017", "2016"], ["Intrinsic value", "$9", "$10", "$18"], ["Exercise proceeds", "7", "11", "15"], ["Income tax benefit realized", "2", "3", "6"]]}

Question: by how much did the intrinsic value decrease from 2016 to 2018?
Evidence:
table_1: the intrinsic value of 2018 is $ 9 ; the intrinsic value of 2017 is $ 10 ; the intrinsic value of 2016 is $ 18 ;
Program: subtract(9, 18), divide(#0, 18)
Answer:
str_answer: -50.0%
exe_answer: -0.5
{"pre_text": ["intangible asset amortization expense amounted to $ 12 million , $ 4 million and $ 4 million for the years ended december 31 , 2018 , 2017 and 2016 , respectively .", "estimated amortization expense for the next five years subsequent to december 31 , 2018 is as follows: ."], "post_text": ["note 9 : shareholders 2019 equity common stock under the dividend reinvestment and direct stock purchase plan ( the 201cdrip 201d ) , shareholders may reinvest cash dividends and purchase additional company common stock , up to certain limits , through the plan administrator without commission fees .", "shares purchased by participants through the drip may be newly issued shares , treasury shares , or at the company 2019s election , shares purchased by the plan administrator in the open market or in privately negotiated transactions .", "purchases generally will be made and credited to drip accounts once each week .", "as of december 31 , 2018 , there were approximately 4.2 million shares available for future issuance under the drip .", "anti-dilutive stock repurchase program in february 2015 , the company 2019s board of directors authorized an anti-dilutive stock repurchase program , which allowed the company to purchase up to 10 million shares of its outstanding common stock over an unrestricted period of time .", "the company repurchased 0.6 million shares and 0.7 million shares of common stock in the open market at an aggregate cost of $ 45 million and $ 54 million under this program for the years ended december 31 , 2018 and 2017 , respectively .", "as of december 31 , 2018 , there were 5.5 million shares of common stock available for purchase under the program. ."], "table": [["", "amount"], ["2019", "$ 15"], ["2020", "13"], ["2021", "11"], ["2022", "10"], ["2023", "7"]], "table_ori": [["", "Amount"], ["2019", "$15"], ["2020", "13"], ["2021", "11"], ["2022", "10"], ["2023", "7"]]}

Question: the company repurchased how many million shares of common stock in the open market for the years ended december 31 , 2018 and 2017?
Evidence:
text_7: the company repurchased 0.6 million shares and 0.7 million shares of common stock in the open market at an aggregate cost of $ 45 million and $ 54 million under this program for the years ended december 31 , 2018 and 2017 , respectively .
Program: add(0.6, 0.7)
Answer:
exe_answer: 1.3
{"pre_text": ["intangible asset amortization expense amounted to $ 12 million , $ 4 million and $ 4 million for the years ended december 31 , 2018 , 2017 and 2016 , respectively .", "estimated amortization expense for the next five years subsequent to december 31 , 2018 is as follows: ."], "post_text": ["note 9 : shareholders 2019 equity common stock under the dividend reinvestment and direct stock purchase plan ( the 201cdrip 201d ) , shareholders may reinvest cash dividends and purchase additional company common stock , up to certain limits , through the plan administrator without commission fees .", "shares purchased by participants through the drip may be newly issued shares , treasury shares , or at the company 2019s election , shares purchased by the plan administrator in the open market or in privately negotiated transactions .", "purchases generally will be made and credited to drip accounts once each week .", "as of december 31 , 2018 , there were approximately 4.2 million shares available for future issuance under the drip .", "anti-dilutive stock repurchase program in february 2015 , the company 2019s board of directors authorized an anti-dilutive stock repurchase program , which allowed the company to purchase up to 10 million shares of its outstanding common stock over an unrestricted period of time .", "the company repurchased 0.6 million shares and 0.7 million shares of common stock in the open market at an aggregate cost of $ 45 million and $ 54 million under this program for the years ended december 31 , 2018 and 2017 , respectively .", "as of december 31 , 2018 , there were 5.5 million shares of common stock available for purchase under the program. ."], "table": [["", "amount"], ["2019", "$ 15"], ["2020", "13"], ["2021", "11"], ["2022", "10"], ["2023", "7"]], "table_ori": [["", "Amount"], ["2019", "$15"], ["2020", "13"], ["2021", "11"], ["2022", "10"], ["2023", "7"]]}

Question: at what price per share did awk repurchase its shares of common stock in 2018?
Evidence:
text_7: the company repurchased 0.6 million shares and 0.7 million shares of common stock in the open market at an aggregate cost of $ 45 million and $ 54 million under this program for the years ended december 31 , 2018 and 2017 , respectively .
Program: divide(45, 0.6)
Answer:
str_answer: 75.00
exe_answer: 75
{"pre_text": ["intangible asset amortization expense amounted to $ 12 million , $ 4 million and $ 4 million for the years ended december 31 , 2018 , 2017 and 2016 , respectively .", "estimated amortization expense for the next five years subsequent to december 31 , 2018 is as follows: ."], "post_text": ["note 9 : shareholders 2019 equity common stock under the dividend reinvestment and direct stock purchase plan ( the 201cdrip 201d ) , shareholders may reinvest cash dividends and purchase additional company common stock , up to certain limits , through the plan administrator without commission fees .", "shares purchased by participants through the drip may be newly issued shares , treasury shares , or at the company 2019s election , shares purchased by the plan administrator in the open market or in privately negotiated transactions .", "purchases generally will be made and credited to drip accounts once each week .", "as of december 31 , 2018 , there were approximately 4.2 million shares available for future issuance under the drip .", "anti-dilutive stock repurchase program in february 2015 , the company 2019s board of directors authorized an anti-dilutive stock repurchase program , which allowed the company to purchase up to 10 million shares of its outstanding common stock over an unrestricted period of time .", "the company repurchased 0.6 million shares and 0.7 million shares of common stock in the open market at an aggregate cost of $ 45 million and $ 54 million under this program for the years ended december 31 , 2018 and 2017 , respectively .", "as of december 31 , 2018 , there were 5.5 million shares of common stock available for purchase under the program. ."], "table": [["", "amount"], ["2019", "$ 15"], ["2020", "13"], ["2021", "11"], ["2022", "10"], ["2023", "7"]], "table_ori": [["", "Amount"], ["2019", "$15"], ["2020", "13"], ["2021", "11"], ["2022", "10"], ["2023", "7"]]}

Question: what is total intangible asset amortization expense ( millions ) for the years ended december 31 , 2018 , 2017 and 2016?
Evidence:
text_0: intangible asset amortization expense amounted to $ 12 million , $ 4 million and $ 4 million for the years ended december 31 , 2018 , 2017 and 2016 , respectively .
Program: add(12, const_4), add(#0, const_4)
Answer:
str_answer: 20
exe_answer: 20
{"pre_text": ["intangible asset amortization expense amounted to $ 12 million , $ 4 million and $ 4 million for the years ended december 31 , 2018 , 2017 and 2016 , respectively .", "estimated amortization expense for the next five years subsequent to december 31 , 2018 is as follows: ."], "post_text": ["note 9 : shareholders 2019 equity common stock under the dividend reinvestment and direct stock purchase plan ( the 201cdrip 201d ) , shareholders may reinvest cash dividends and purchase additional company common stock , up to certain limits , through the plan administrator without commission fees .", "shares purchased by participants through the drip may be newly issued shares , treasury shares , or at the company 2019s election , shares purchased by the plan administrator in the open market or in privately negotiated transactions .", "purchases generally will be made and credited to drip accounts once each week .", "as of december 31 , 2018 , there were approximately 4.2 million shares available for future issuance under the drip .", "anti-dilutive stock repurchase program in february 2015 , the company 2019s board of directors authorized an anti-dilutive stock repurchase program , which allowed the company to purchase up to 10 million shares of its outstanding common stock over an unrestricted period of time .", "the company repurchased 0.6 million shares and 0.7 million shares of common stock in the open market at an aggregate cost of $ 45 million and $ 54 million under this program for the years ended december 31 , 2018 and 2017 , respectively .", "as of december 31 , 2018 , there were 5.5 million shares of common stock available for purchase under the program. ."], "table": [["", "amount"], ["2019", "$ 15"], ["2020", "13"], ["2021", "11"], ["2022", "10"], ["2023", "7"]], "table_ori": [["", "Amount"], ["2019", "$15"], ["2020", "13"], ["2021", "11"], ["2022", "10"], ["2023", "7"]]}

Question: at what price per share did awk repurchase its shares of common stock in 2017?
Evidence:
text_7: the company repurchased 0.6 million shares and 0.7 million shares of common stock in the open market at an aggregate cost of $ 45 million and $ 54 million under this program for the years ended december 31 , 2018 and 2017 , respectively .
Program: divide(54, 0.7)
Answer:
str_answer: 77.1
exe_answer: 77.14286
{"pre_text": ["humana inc .", "notes to consolidated financial statements 2014 ( continued ) the total intrinsic value of stock options exercised during 2007 was $ 133.9 million , compared with $ 133.7 million during 2006 and $ 57.8 million during 2005 .", "cash received from stock option exercises for the years ended december 31 , 2007 , 2006 , and 2005 totaled $ 62.7 million , $ 49.2 million , and $ 36.4 million , respectively .", "total compensation expense related to nonvested options not yet recognized was $ 23.6 million at december 31 , 2007 .", "we expect to recognize this compensation expense over a weighted average period of approximately 1.6 years .", "restricted stock awards restricted stock awards are granted with a fair value equal to the market price of our common stock on the date of grant .", "compensation expense is recorded straight-line over the vesting period , generally three years from the date of grant .", "the weighted average grant date fair value of our restricted stock awards was $ 63.59 , $ 54.36 , and $ 32.81 for the years ended december 31 , 2007 , 2006 , and 2005 , respectively .", "activity for our restricted stock awards was as follows for the year ended december 31 , 2007 : shares weighted average grant-date fair value ."], "post_text": ["the fair value of shares vested during the years ended december 31 , 2007 , 2006 , and 2005 was $ 3.4 million , $ 2.3 million , and $ 0.6 million , respectively .", "total compensation expense related to nonvested restricted stock awards not yet recognized was $ 44.7 million at december 31 , 2007 .", "we expect to recognize this compensation expense over a weighted average period of approximately 1.4 years .", "there are no other contractual terms covering restricted stock awards once vested. ."], "table": [["", "shares", "weighted average grant-date fair value"], ["nonvested restricted stock at december 31 2006", "1107455", "$ 45.86"], ["granted", "852353", "63.59"], ["vested", "-51206 ( 51206 )", "56.93"], ["forfeited", "-63624 ( 63624 )", "49.65"], ["nonvested restricted stock at december 31 2007", "1844978", "$ 53.61"]], "table_ori": [["", "Shares", "Weighted Average Grant-Date Fair Value"], ["Nonvested restricted stock at December 31, 2006", "1,107,455", "$45.86"], ["Granted", "852,353", "63.59"], ["Vested", "(51,206)", "56.93"], ["Forfeited", "(63,624)", "49.65"], ["Nonvested restricted stock at December 31, 2007", "1,844,978", "$53.61"]]}

Question: for the year ended december 31 , 2007 what was the ratio of the shares granted to the shares vested
Evidence:
table_2: the granted of shares is 852353 ; the granted of weighted average grant-date fair value is 63.59 ;
table_3: the vested of shares is -51206 ( 51206 ) ; the vested of weighted average grant-date fair value is 56.93 ;
Program: divide(852353, 51206)
Answer:
str_answer: 16.65
exe_answer: 16.64557
{"pre_text": ["humana inc .", "notes to consolidated financial statements 2014 ( continued ) the total intrinsic value of stock options exercised during 2007 was $ 133.9 million , compared with $ 133.7 million during 2006 and $ 57.8 million during 2005 .", "cash received from stock option exercises for the years ended december 31 , 2007 , 2006 , and 2005 totaled $ 62.7 million , $ 49.2 million , and $ 36.4 million , respectively .", "total compensation expense related to nonvested options not yet recognized was $ 23.6 million at december 31 , 2007 .", "we expect to recognize this compensation expense over a weighted average period of approximately 1.6 years .", "restricted stock awards restricted stock awards are granted with a fair value equal to the market price of our common stock on the date of grant .", "compensation expense is recorded straight-line over the vesting period , generally three years from the date of grant .", "the weighted average grant date fair value of our restricted stock awards was $ 63.59 , $ 54.36 , and $ 32.81 for the years ended december 31 , 2007 , 2006 , and 2005 , respectively .", "activity for our restricted stock awards was as follows for the year ended december 31 , 2007 : shares weighted average grant-date fair value ."], "post_text": ["the fair value of shares vested during the years ended december 31 , 2007 , 2006 , and 2005 was $ 3.4 million , $ 2.3 million , and $ 0.6 million , respectively .", "total compensation expense related to nonvested restricted stock awards not yet recognized was $ 44.7 million at december 31 , 2007 .", "we expect to recognize this compensation expense over a weighted average period of approximately 1.4 years .", "there are no other contractual terms covering restricted stock awards once vested. ."], "table": [["", "shares", "weighted average grant-date fair value"], ["nonvested restricted stock at december 31 2006", "1107455", "$ 45.86"], ["granted", "852353", "63.59"], ["vested", "-51206 ( 51206 )", "56.93"], ["forfeited", "-63624 ( 63624 )", "49.65"], ["nonvested restricted stock at december 31 2007", "1844978", "$ 53.61"]], "table_ori": [["", "Shares", "Weighted Average Grant-Date Fair Value"], ["Nonvested restricted stock at December 31, 2006", "1,107,455", "$45.86"], ["Granted", "852,353", "63.59"], ["Vested", "(51,206)", "56.93"], ["Forfeited", "(63,624)", "49.65"], ["Nonvested restricted stock at December 31, 2007", "1,844,978", "$53.61"]]}

Question: what is the increase observed in the weighted average grant date fair value of the restricted stocks in 2006 and 2007?
Evidence:
text_7: the weighted average grant date fair value of our restricted stock awards was $ 63.59 , $ 54.36 , and $ 32.81 for the years ended december 31 , 2007 , 2006 , and 2005 , respectively .
Program: divide(63.59, 54.36), subtract(#0, const_1)
Answer:
str_answer: 16.97%
exe_answer: 0.16979